IL126453A0 - New triazolopurines method of preparing them and their use as drugs - Google Patents

New triazolopurines method of preparing them and their use as drugs

Info

Publication number
IL126453A0
IL126453A0 IL12645397A IL12645397A IL126453A0 IL 126453 A0 IL126453 A0 IL 126453A0 IL 12645397 A IL12645397 A IL 12645397A IL 12645397 A IL12645397 A IL 12645397A IL 126453 A0 IL126453 A0 IL 126453A0
Authority
IL
Israel
Prior art keywords
optionally substituted
alkyl
alkenyl
alkynyl
cycloalkyl
Prior art date
Application number
IL12645397A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Priority claimed from CA002242097A external-priority patent/CA2242097C/fr
Publication of IL126453A0 publication Critical patent/IL126453A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36Antigestagens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12645397A 1996-07-20 1997-07-17 New triazolopurines method of preparing them and their use as drugs IL126453A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19629378A DE19629378A1 (de) 1996-07-20 1996-07-20 Neue Triazolopurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
PCT/EP1997/003841 WO1998003511A1 (fr) 1996-07-20 1997-07-17 Nouvelles triazolopurines, procede pour les preparer et leur utilisation comme medicaments
CA002242097A CA2242097C (fr) 1996-07-20 1998-06-26 Imidazotriazolopyrimidines, procedes pour les preparer, et leur utilisation en tant que compositions pharmaceutiques

Publications (1)

Publication Number Publication Date
IL126453A0 true IL126453A0 (en) 1999-08-17

Family

ID=32963000

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12645397A IL126453A0 (en) 1996-07-20 1997-07-17 New triazolopurines method of preparing them and their use as drugs

Country Status (25)

Country Link
EP (2) EP0880524B1 (fr)
JP (1) JP3020281B2 (fr)
CN (1) CN1219936A (fr)
AT (1) ATE191913T1 (fr)
AU (1) AU3695597A (fr)
BG (1) BG102707A (fr)
BR (1) BR9710747A (fr)
CA (1) CA2256736A1 (fr)
CZ (1) CZ265498A3 (fr)
DE (2) DE19629378A1 (fr)
DK (1) DK0880524T3 (fr)
EE (1) EE9800451A (fr)
ES (1) ES2147453T3 (fr)
GR (1) GR3033842T3 (fr)
HR (1) HRP970395A2 (fr)
HU (1) HUP9902311A3 (fr)
ID (1) ID19106A (fr)
IL (1) IL126453A0 (fr)
NO (1) NO983860L (fr)
PL (1) PL328824A1 (fr)
PT (1) PT880524E (fr)
SK (1) SK114498A3 (fr)
TR (1) TR199801659T2 (fr)
WO (1) WO1998003511A1 (fr)
ZA (1) ZA976331B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826843A1 (de) * 1998-06-16 1999-12-23 Boehringer Ingelheim Pharma Neue Imidazotriazolopyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6492377B1 (en) 1998-06-25 2002-12-10 Boehringer Ingelheim Pharma Kg Imidazotriazolopyrimidines with adenosine-antagonistic activity
AU9347498A (en) * 1998-08-27 2000-03-21 Boehringer Ingelheim Pharma Kg Imidazotriazolopyrimidines
WO2004075846A2 (fr) 2003-02-25 2004-09-10 Bristol-Myers Squibb Company Composes tricycliques a base de pyrazolopurine et compositions pharmaceutiques renfermant ces composes
US7071333B2 (en) 2003-07-30 2006-07-04 Bristol-Myers Squibb Company Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
KR20090025261A (ko) 2006-06-23 2009-03-10 인사이트 코포레이션 Hm74a 아고니스트로서의 퓨리논 유도체
CR20200441A (es) 2018-02-27 2021-03-15 Incyte Corp Imidazopirimidinas y triazolopirimidinas como inhibidores de a2a / a2b
MX2020012376A (es) 2018-05-18 2021-03-09 Incyte Corp Derivados de pirimidina fusionados como inhibidores de los receptores de adenosina a2a/a2b.
TWI829857B (zh) 2019-01-29 2024-01-21 美商英塞特公司 作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶
CN112778311A (zh) * 2019-11-01 2021-05-11 上海翰森生物医药科技有限公司 含氮并环类衍生物抑制剂、其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA902282B (en) * 1989-03-29 1990-12-28 Merrell Dow Pharma Selective adenosine receptor compounds
IT1264901B1 (it) * 1993-06-29 1996-10-17 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina
JPH083169A (ja) * 1994-06-15 1996-01-09 Yamasa Shoyu Co Ltd 4−メチル−1H−[1,2,4]トリアゾロ[1,5−a]プリン−9(4H)−オン類

Also Published As

Publication number Publication date
EP0880524A1 (fr) 1998-12-02
GR3033842T3 (en) 2000-10-31
PL328824A1 (en) 1999-02-15
EE9800451A (et) 1999-06-15
BR9710747A (pt) 1999-08-17
PT880524E (pt) 2000-07-31
HUP9902311A2 (hu) 1999-10-28
WO1998003511A1 (fr) 1998-01-29
NO983860L (no) 1998-10-21
DE59701467D1 (de) 2000-05-25
ID19106A (id) 1998-06-18
BG102707A (en) 1999-09-30
NO983860D0 (no) 1998-08-21
HRP970395A2 (en) 1998-08-31
EP0978517A2 (fr) 2000-02-09
TR199801659T2 (xx) 1998-12-21
CA2256736A1 (fr) 1998-01-29
DE19629378A1 (de) 1998-01-29
JP2000501420A (ja) 2000-02-08
ZA976331B (en) 1999-01-25
CN1219936A (zh) 1999-06-16
CZ265498A3 (cs) 1998-12-16
DK0880524T3 (da) 2000-07-17
ES2147453T3 (es) 2000-09-01
AU3695597A (en) 1998-02-10
EP0978517A3 (fr) 2003-11-12
ATE191913T1 (de) 2000-05-15
EP0880524B1 (fr) 2000-04-19
JP3020281B2 (ja) 2000-03-15
SK114498A3 (en) 1999-02-11
HUP9902311A3 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
GR3033842T3 (en) New triazolopurines, method of preparing them and their use as drugs
FI953089A (fi) Boorihaposta johdetut uudet peptidiyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
ATE255580T1 (de) Cycloalkano-indol- und -azaindol-derivate
ES8601213A1 (es) Derivados de cefalosporina
HK1071892A1 (en) New camptothecin analogue compounds, a process fortheir preparation and pharmaceutical compositions containing them
HK1026201A1 (en) New cyclic compounds having a cycloalkylene chain,a process for their prepartion and pharmaceutical compositions containing them
HK1014956A1 (en) Substituted benzoheterocyclic compounds, a process for their preparation and pharmaceutical compositions containing them
ZA9710649B (en) Benzopyran compounds, process for preparing them and pharmaceutical compositions containing them.